Fluoxetine, a selective serotonin reuptake inhibitor, is neuroprotective; therefore, it has been
applied to treat some neurodegenerative disorders. For instance, chronic fluoxetine …

Fluoxetine (FLX) has broad neurobiological functions and neuroprotective effects; however,
the preventive effects of FLX on cognitive impairments in Alzheimer's disease (AD) have not …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with
cognitive decline. Previous studies have reported that the syndrome of AD begins with …

Oligodendrogenesis dysfunction impairs memory consolidation in adult mice, and an
oligodendrocyte abnormality is an important change occurring in Alzheimer's disease (AD) …

Fluoxetine, one of the selective serotonin reuptake inhibitor (SSRI) antidepressants, has
been thought to be effective for treating post-stroke depression (PSD). Recent work has …

Neuroplasticity and inflammation represent a common final pathway for effective
antidepressant treatment. SSRIs are the most commonly prescribed medications for …

Radiation therapy and concomitant temozolomide chemotherapy are commonly used in
treatment of brain tumors, but they may also result in behavioral impairments such as anxiety …

Selective serotonin reuptake inhibitors (SSRIs) have been reported to increase cognitive
performance in some clinical studies of Alzheimer's disease (AD). However, there is a lack of …

Background: Studies have suggested that cognitive impairment in Alzheimer's disease (AD)
is associated with dendritic spine loss, especially in the hippocampus. Fluoxetine (FLX) has …

Fluoxetine (FLX) is one of the selective serotonin reuptake inhibitors (SSRIs)
antidepressants, which could be used to relieve depression and anxiety among AD patients …